Drug Profile
RD 42227
Latest Information Update: 16 Jun 1998
Price :
$50
*
At a glance
- Originator Rational Drug Design Laboratories
- Developer Rational Drug Design Laboratories; Tosoh
- Class Antivirals
- Mechanism of Action HIV fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 16 Jun 1998 Discontinued-Preclinical for HIV-1 infections in Japan (Unknown route)
- 22 Oct 1996 New profile
- 22 Oct 1996 Preclinical development for HIV-1 infections in Japan (Unknown route)